39 results
Page 2 of 2
8-K
EX-99.2
ub0ks
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
EX-99.1
nhxb895 odqg
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
10-Q
y1h95u40n
14 May 19
Quarterly report
7:47am
DEF 14A
nnypfk jv6dhkw9u4
30 Apr 19
Definitive proxy
4:04pm
10-K
ylo9u7gm j7gqk
22 Mar 19
Annual report
4:45pm
424B4
iulg1kt
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
uqwxu w1tg
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
EX-10.5
fltr2s
23 Jan 19
IPO registration (amended)
4:39pm
S-1
EX-10.5
y36 m7rct9elffmdr2d
21 Dec 18
IPO registration
4:39pm
S-1
gvr qlucc3f1r9s
21 Dec 18
IPO registration
4:39pm
DRS/A
09jsx0 avretz
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
zirh ig0nexjen3emt
11 Oct 18
Draft registration statement
12:00am